Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bruce David Walker, M.D.

Co-Author

This page shows the publications co-authored by Bruce Walker and Rajesh Gandhi.
Connection Strength

1.722
  1. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis. 2003 Dec 15; 37(12):1693-8.
    View in: PubMed
    Score: 0.291
  2. Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection. Curr Opin Immunol. 2002 Aug; 14(4):487-94.
    View in: PubMed
    Score: 0.266
  3. Immunologic control of HIV-1. Annu Rev Med. 2002; 53:149-72.
    View in: PubMed
    Score: 0.255
  4. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. Lancet HIV. 2019 04; 6(4):e259-e268.
    View in: PubMed
    Score: 0.210
  5. Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial. . 2016 Mar 01; 71(3):246-53.
    View in: PubMed
    Score: 0.170
  6. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS One. 2007 Mar 28; 2(3):e321.
    View in: PubMed
    Score: 0.092
  7. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 2006 Dec; 3(12):e492.
    View in: PubMed
    Score: 0.090
  8. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J Virol. 2005 Oct; 79(20):12979-88.
    View in: PubMed
    Score: 0.083
  9. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol. 2002 Dec; 76(24):12584-95.
    View in: PubMed
    Score: 0.068
  10. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018 11 05; 218(12):1954-1963.
    View in: PubMed
    Score: 0.051
  11. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy. PLoS Pathog. 2017 Sep; 13(9):e1006629.
    View in: PubMed
    Score: 0.047
  12. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7.
    View in: PubMed
    Score: 0.029
  13. Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells. Cancer Res. 2008 Nov 15; 68(22):9441-50.
    View in: PubMed
    Score: 0.026
  14. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med. 2007 Nov 26; 204(12):2813-24.
    View in: PubMed
    Score: 0.024
  15. CD8 epitope escape and reversion in acute HCV infection. J Exp Med. 2004 Dec 20; 200(12):1593-604.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.